The analysis revealed that the GBM CAF secretome upregulated cancer progression pathways, including HIF-1α, EMT, and cell proliferation in GSCs (Figure 3, A and B, and Supplemental Figures 16 and 17). This evidence concerns the gene HIF1A and glioblastoma.